Carcinoma in situ

Disease

1 paper1 finding

  • Humans1

Associations

1

Esophageal squamous cell carcinoma

upin humans1

1 study
  1. Carcinoma in situ predicts esophageal squamous cell carcinoma in humans (HR 52.90, 95% CI 26.29-106.46).

    “carcinoma in situ (HR=52.90; 95% CI: 26.29-106.46).”

    Humansesophagus14-year follow-upn = 11,397

    Esophageal squamous cell carcinoma prevention in high-risk, resource-limited rural China: Dysplasia screening and modifiable risk factors in a 14-year follow-up study

    Cancer epidemiology10 Oct 2026

More on Esophageal squamous cell carcinoma

Trial sponsors

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 4Sep 2026: 4Oct 2026: 412 in 12 months
The Lancet Oncology

3D breast screening may reduce cancers between scans

Over 24 months after a negative screen, invasive cancer rates were 14.2 per 10,000 women with 3D screening versus 18.6 with standard mammography.Over 24 months after a negative screen, invasive cancer rates were 14.2 per 10,000 women with 3D screening versus 18.6 with standard mammography.

Randomised trial in screen-negative women in Germany, 24 months, against standard digital mammographyInterventions

Limit: The primary comparison was inconclusive; the range of likely effects included no difference